Japan Authorizes Shionogi's Updated COVID-19 Vaccine for Upcoming Season
Japan has granted partial change approval for Shionogi's COVGOZE® COVID-19 vaccine, updating its antigen strain to Omicron LP.8.1. This aligns the vaccine with the recommended strain for the 2026/2027 vaccination season. Shionogi & Co., Ltd. is now preparing to supply the updated vaccine within fiscal year 2026.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.
Open NewsSnap.ai